KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 123 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $780,878 | -51.4% | 656,200 | 0.0% | 0.07% | -43.1% |
| Q2 2023 | $1,607,690 | -21.7% | 656,200 | 0.0% | 0.13% | -23.5% |
| Q1 2023 | $2,053,906 | -55.5% | 656,200 | 0.0% | 0.17% | -56.9% |
| Q4 2022 | $4,619,648 | -18.2% | 656,200 | 0.0% | 0.39% | -11.9% |
| Q3 2022 | $5,650,000 | +4.1% | 656,200 | 0.0% | 0.45% | -5.5% |
| Q2 2022 | $5,427,000 | -50.2% | 656,200 | 0.0% | 0.47% | -43.9% |
| Q1 2022 | $10,906,000 | -0.6% | 656,200 | 0.0% | 0.84% | +20.3% |
| Q4 2021 | $10,972,000 | +93.5% | 656,200 | 0.0% | 0.70% | +105.0% |
| Q3 2021 | $5,670,000 | +59.1% | 656,200 | 0.0% | 0.34% | +74.5% |
| Q2 2021 | $3,563,000 | -8.9% | 656,200 | 0.0% | 0.20% | -12.1% |
| Q1 2021 | $3,911,000 | +36.7% | 656,200 | +19.7% | 0.22% | +48.7% |
| Q4 2020 | $2,862,000 | +20.9% | 548,206 | +12.0% | 0.15% | +15.4% |
| Q3 2020 | $2,368,000 | +123.0% | 489,319 | +138.6% | 0.13% | +103.1% |
| Q2 2020 | $1,062,000 | – | 205,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |